irbesartan

(redirected from Avapro)
Also found in: Medical.
Related to Avapro: irbesartan

ir·be·sar·tan

 (ĭr′bə-sär′tn)
n.
An angiotensin II receptor blocker drug, C25H28 N6O, used to treat hypertension.

[irbe-, origin unknown + -sartan, angiotensin II receptor blocker suff.; see losartan.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

irbesartan

n irbesartán m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The latestA recall affected losartan (Cozaar), valsartan (Diovan and Prexxartan) and irbesartan (Avapro).A ARBs are known for helping reduce blood pressure.
Angiotensin II Avapro (irbesartan) Benicar or Receptor Antagonists Avapro Antidepressants Effexor (venlaxafine) Cymbalta v.
But the hypertension market growth will be countered by significant drug patent expirations both prior to and during the forecast period, including those of Cozaar in 2010, Diovan, Avapro and Atacand in 2012, Exforge in 2014, Benicar in 2016, and Tekturna and Tekturna HCT in 2018.
Two drugs, telmisartan (Micardis) and valsartan (Diovan) were found to do a better job than three others--candesartan (Atacand), irbesartan (Avapro) or losartan (Cozaar)--at reducing hospital admissions for heart attack, heart failure and stroke in 54,000 Ontario seniors with diabetes.
Some commonly prescribed drugs in this class are candesartan (Atacand), eprosartan (Teveten), irbesarten (Avapro), losartan (Cozaar), telmisartan (Micardis) and valsartan (Diovan).
Sales plunged 27% to $3.83bn, slightly below Wall Street expectations of $3.88bn, as the company's Avapro blood pressure drug and Plavix blood clot preventer faced competition from cheaper generics.
The medicines to be distributed include Plavix, Avapro and Meformin.
Blood pressure drugs Avapro and Avalide, which lost patent protection last March, dropped 57 percent to $84 million.
M2 EQUITYBITES-October 15, 2012-Watson Pharmaceuticals Inc to launch generic Avapro today following FDA approval(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-October 15, 2012-Watson Pharmaceuticals Inc to launch generic Avapro today following FDA approval(C)2012 M2 COMMUNICATIONS